Jupiter Regenerative Medicine

Jupiter Regenerative Medicine

NovaGenix provides physician-led regenerative medicine consultations in Jupiter, Florida. Treatment recommendations are individualized after medical evaluation, with discussion of the specific biologic product being considered, its FDA status, the available evidence, potential risks, alternatives, and realistic expectations.

NovaGenix does not currently offer platelet-rich plasma (PRP). PRP is prepared from a patient's own blood and is not interchangeable with stem-cell or other cellular therapies. Products differ in source, composition, evidence and regulatory status. A consultation reviews the diagnosis, medical history, prior treatments, relevant imaging, goals and alternatives; no regenerative treatment can guarantee healing or avoidance of surgery.

Regenerative medicine examines how cells, tissues, and biologic materials may influence healing, inflammation, and tissue function. Research is ongoing, and results vary by diagnosis, product, and patient. These therapies should not be presented as guaranteed substitutes for surgery or other established treatments.

These research reviews explain cell biology and investigational applications; they do not establish that a particular clinic product is effective or FDA-approved:

• Stem cell-based therapy for human diseases
• An introduction to stem cells
• Stem cells: a comprehensive review of origins and emerging clinical roles in medical practice
• Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine

What Are Stem cells

Stem cells can self-renew and develop into specialized cell types, with capabilities that differ by cell type. Embryonic, adult and induced pluripotent stem cells have different characteristics and research applications. Cell biology alone does not demonstrate that a processed product will safely repair tissue in a patient.

FDA approval is specific to the product and indication. Approved cellular therapies include cord-blood products for certain blood and immune disorders and Ryoncil (remestemcel-L-rknd), approved in December 2024 for steroid-refractory acute graft-versus-host disease in children aged 2 months and older. Consult the FDA list of approved cellular and gene therapy products for product-specific information. These approvals do not establish that other products, sources or uses are approved or effective.

FDA approval of a cellular therapy for a specific disease does not mean stem-cell injections are approved for arthritis, joint pain, sports injuries or anti-aging.

For the most recent information about clinical trials you can visit the website ClinicalTrials.gov. A trial listing or FDA registration is not proof of FDA approval, demonstrated benefit or appropriate regulatory authorization.

Questions to Ask Before Regenerative Treatment

Ask for clear, product-specific answers before deciding on treatment. A result from a study of one cell type or preparation cannot automatically be applied to another. Established treatments and specialist evaluation may be more appropriate for your diagnosis.

Bring your diagnosis, prior treatment history and relevant imaging to the consultation, and ask:

• What exact product would be used, where does it come from, and how is it processed?
• Is that specific product FDA-approved for my proposed use? If not, what regulatory pathway applies?
• What human evidence supports this product for my diagnosis, and what benefits and uncertainties should I expect?
• What risks are known, and how does this compare with physical therapy, medication, surgery or other established options?
• What follow-up is required, what will treatment cost, and who should I contact if a complication occurs? Be cautious of guarantees of cartilage regrowth, healing or avoiding surgery.

What is Stem Cell Therapy?

In recent years, stem cell therapy has become an extremely promising area of medicine and topic in advanced scientific research. Stem cell therapy is a medical approach that involves using stem cells to treat or prevent diseases or conditions. Stem cells are known for their unique ability to develop into various cell types and may be manipulated and guided to replace damaged or diseased cells, promoting regeneration and repair in the body. This is a promising field of therapy and holds huge potential for treating a wide range of medical conditions, from degenerative diseases to injuries and more.

Where Do Stem Cells Come From?

Stem cells can be sourced from various places in the body, including embryonic tissue, fetal tissue, and adult tissues. Embryonic stem cells are derived from embryos, fetal stem cells come from the tissue of developingfetuses, and adult stem cells are found in various tissues throughout the body, such as the bone marrow, adipose tissue (fat), and blood. Additionally, induced pluripotent stem cells (iPSCs) can be created by reprogramming adult cells, providing a versatile source for therapeutic purposes.

Each source has its own advantages and limitations in terms of differentiation potential and ethical considerations. The hopes are that in the future, stem cell treatments can be used more widely and safely to treat a large variety of medical conditions.

What Are Umbilical Cord Stem Cells?

Umbilical cord stem cells are a type of stem cell which are obtained from the umbilical cord and placenta after childbirth. Donors are often tested and screened and donate the tissue after a c-section birth. These cells, known as cord blood stem cells, are rich in hematopoietic stem cells, which can develop into various blood cell types.

Certain cord-blood products are FDA-approved for disorders affecting blood formation. Cord blood, cord tissue and Wharton's jelly products are different materials; approval or evidence for one does not establish approval or benefit for another.

What is Wharton’s Jelly?

Wharton's jelly is a gelatinous substance found in the umbilical cord. It surrounds and protects the blood vessels of the umbilical cord, providing structural support. Wharton's jelly contains various components, including mesenchymal stem cells (MSCs), which have the potential to differentiate into different cell types. Due to the presence of these stem cells, Wharton's jelly has gained attention in medical research and regenerative medicine. It is considered a valuable source of mesenchymal stem cells for potential therapeutic applications.

What are Embryonic Stem Cells?

Embryonic stem cells are pluripotent cells derived from the inner cell mass of a developing embryo. These cells have the remarkable ability todifferentiate into any cell type in the human body. Their pluripotency makes them valuable for research and potential therapeutic applications, as they can be directed to become specific cell types needed for various tissues or organs. However, the use of embryonic stem cells is a topic of ethical debate, as their extraction typically involves the destruction of the embryo.

Advances in technology have led to the development of alternative sources of pluripotent stem cells, such as induced pluripotent stem cells (iPSCs), which can be generated without using embryos.

What are Adult Stem Cells?

Adult stem cells, also known as somatic or multipotent stem cells, are undifferentiated cells found in various tissues of the body. Unlike embryonic stem cells, adult stem cells are more specialized, typically committed to generating the cell types specific to the tissue or organ from which they originate. These cells play a crucial role in tissue repair and regeneration throughout a person's life.

Common sources of adult stem cells include the bone marrow, adipose tissue (fat), blood, and various organs. Research on adult stem cells explores their potential for treating diseases and injuries by harnessing their capacity to differentiate into specific cell types.

Stem-cell research spans many diseases. Established blood-forming stem-cell transplantation and product-specific FDA approvals should be distinguished from investigational applications:

• Blood Disorders: Treating conditions like leukemia and other blood-related diseases through hematopoietic stem cell transplantation.
• Orthopedic Issues: Research into musculoskeletal conditions does not establish that marketed injections regrow cartilage, heal injuries or replace surgery.
• Autoimmune Diseases: Exploring stem cells' immunomodulatory properties to potentially mitigate the effects of autoimmune disorders.
• Neurological Disorders: Investigating the use of stem cells in the treatment of conditions like Parkinson's disease, Alzheimer's disease, and spinal cord injuries.
• Heart Disease: Studying the potential of stem cells in regenerating heart tissue damaged by heart attacks or other cardiovascular diseases.
• Diabetes: Researching ways to replace or regenerate pancreatic cells to treat diabetes.
• Cosmetic and Anti-Aging Procedures: Investigational and marketed uses should not be treated as established, FDA-approved treatments for rejuvenation or hair restoration.

It's important to note that while there is significant promise in stem cell therapy, research is ongoing, and not all applications have reached widespread clinical use and are often not approved by the FDA. Additionally, ethical considerations and regulatory frameworks play a role in the development and implementation of stem cell treatments. However, the field of stem cell therapy is dynamic, and regulations may evolve.

It's important for individuals considering stem cell treatments to consult with reputable healthcare professionals and ensure that any therapy they are considering complies with current regulatory standards. Clinical trials, when conducted under proper oversight, are one legitimate pathway for exploring the safety and efficacy of stem cell therapies.